Goldman Sachs Downgrades Vitamin Shoppe To Neutral

Analysts at Goldman Sachs downgraded Vitamin Shoppe

from Buy to Neutral. The price target for Vitamin Shoppe has been lowered from $49 to $48. Vitamin Shoppe shares have dropped 7.74% over the past 52 weeks, while the S&P 500 index has gained 14.72% in the same period. Vitamin Shoppe's shares rose 3.59% to close at $47.07 yesterday.